Monocloneantibody Development Platform
Mycenax’ Monocloneantibody Development Platform speeds up the development of the manufacturing process and analytical methods for your monoclonal antibody.
Technology Platform
- Cell Culture Process Development
- Limited media and feed finetuning by mini-bioreactor
- Cell culture adaptation by 5L scale bioreactor
- Purification Process Development
- Consists of three column steps, one virus inactivation step, and one nanofiltration step
- Limited development to remove the impurity to a safety level
- Analytical Method Development
- Test of in-house established analytical methods for suitability
- If platform methods are not suitable, customized method development possible
- Process development time can be shortened to 6 months